S'abonner

IMMUNIZATIONS AND TRAVEL - 10/09/11

Doi : 10.1016/S0733-8627(05)70285-6 
Wendy T. Thanassi, MA, MD *, Eric L. Weiss, MD, DTM & H, FACEP *

Résumé

International travel exposes people to health risks that they do not encounter in the United States because of a greater number of infectious diseases and diseases that do not exist in this country. A thorough, systematic approach to the needs of the international traveler can prevent illness in the individual and contribute to controlling the spread of nonendemic diseases to the greater population.

Immunizations are so effective that, in what was perhaps the greatest public health initiative the world has ever seen, broad administration of the smallpox vaccine eradicated the disease from the human population. The last reported case of endemic smallpox occurred in Somalia in October 1977. In 1988, the World Health Organization, with similarly high goals, adopted a resolution to eradicate poliomyelitis from the world by the year 2000. Thus far, the last case of wild poliovirus infection reported in the Western Hemisphere was more than 5 years ago.3

Immunization programs, however, have also proved their vulnerability. In 1983, the United States had the lowest number of measles cases ever reported: fewer than 1500. In 1990, the number of cases reported rose to over 27,700.5 This breakthrough is blamed on decreased herd immunity owing to decreased childhood immunization rates, as well as a less immunogenic vaccine antigen before 1980.

Although immunizations are important and effective, the overall approach to the international traveler must be a comprehensive travel medical consult, consisting of a complete history, focused physical examination, and traveler education stressing the imperatives of insect avoidance, food and water precautions, diarrhea management, a travel medicine kit, and immunization needs. Specific “wilderness medicine” advice regarding high altitude, diving, or hostile environments should be addressed as appropriate. Many of the illnesses that affect travelers, such as travelers' diarrhea, are not prevented by “shots,” but immunizations can and do protect people from many potentially life-threatening illnesses.

There is an understanding, particularly in travel medicine, that a balance must be reached between the risks and benefits of immunizations; in the grander scheme, the cost could also be added to the assessment. A prime example is the use of typhoid vaccines: the risk to travelers is estimated to be 1 in 10 million in travelers to Europe and up to 1 in 10,000 if visiting family, friends, or relatives in India, Pakistan, or Peru.18 Currently, it costs approximately $300,000 to prevent one case of typhoid illness in US travelers.1 Thus, the health care provider should use discretion and consider carefully the actual benefit of protection versus cost and the risk of potential side effects when recommending immunizations.

The travel medicine consult and the delivery of vaccines should ideally begin 4 to 8 weeks before departure. A systematic six-step approach, as outlined in this article, will help the provider identify the immunization needs of the individual traveler. Immunization indications can be divided into the six categories listed below (Figure 1).

1
Routine immunizations: Is the patient protected against routine childhood illnesses (measles, influenza, polio, tetanus)?
2
Routine travel immunizations: Is the patient protected against hepatitis A and typhoid fever?
3
Required immunizations: Does the destination country require yellow fever immunization and documentation?
4
Geographically indicated: Which immunizations are needed in order to protect against endemic diseases unique to the traveler's itinerary?
5
Extended stay: Is the duration of the trip going to put the traveler at additional risk?
6
Special groups (pregnant, elderly, children, immunocompromised): Is there increased risk for particular illnesses owing to the traveler's age or health status?

A comprehensive list of immunizations for travelers is included in Table 3.

Le texte complet de cet article est disponible en PDF.

Plan


 Address reprint requests to, Eric L. Weiss, MD, DTM & H, FACEP, SFO Medical Service, San Francisco International Airport, San Francisco, CA 94143


© 1997  W. B. Saunders Company. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 15 - N° 1

P. 43-70 - février 1997 Retour au numéro
Article précédent Article précédent
  • MEDICAL LIMITATIONS TO WILDERNESS TRAVEL
  • Howard Backer
| Article suivant Article suivant
  • TRAVEL WITH INFANTS AND CHILDREN
  • Jill A. Foster, Barbara Watson, Louis M. Bell

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.